about
Endothelial PPAR-γ Protects Against Vascular Thrombosis by Downregulating P-Selectin ExpressionSignificanceApelin is necessary for the maintenance of insulin sensitivity.MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions.Testosterone alleviates tumor necrosis factor-alpha-mediated tissue factor pathway inhibitor downregulation via suppression of nuclear factor-kappa B in endothelial cellsMaking sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction.Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats.Mitogen-activated protein kinases pathway is involved in physiological testosterone-induced tissue factor pathway inhibitor expression in endothelial cells.Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.Resistin increases platelet P-selectin levels via p38 MAPK signal pathway.Increased Carotid Artery Lesion Inflammation Upon Treatment With the CD137 Agonistic Antibody 2A.Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.H19 Induces Abdominal Aortic Aneurysm Development and Progression.Dok-1 negatively regulates platelet integrin αIIbβ3 outside-in signalling and inhibits thrombosis in mice.Four Surgical Modifications to the Classic Elastase Perfusion Aneurysm Model Enable Haemodynamic Alterations and Extended Elastase PerfusionATG16L1 Expression in Carotid Atherosclerotic Plaques Is Associated With Plaque VulnerabilitySonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARγ-LXRα-ABCA1/ABCG1 pathway and promotes cholesterol efflux in advanced plaqueResolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic AneurysmsmiR-29b Mediates the Chronic Inflammatory Response in Radiotherapy-Induced Vascular DiseasePhysiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cellsUrantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar ratsAsymmetric dimethylarginine impairs fibrinolytic activity in human umbilical vein endothelial cells via p38 MAPK and NF-κB pathwaysResistin level is positively correlated with thrombotic complications in Southern Chinese metabolic syndrome patientsLocal Delivery of miR-21 Stabilizes Fibrous Caps in Vulnerable Atherosclerotic Lesions5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Alleviates Atherosclerosis via Enhancing Efferocytosis and Facilitating a Shift in the Th1/Th2 Balance Toward Th2 PolarizationSonodynamic Therapy Suppresses Neovascularization in Atherosclerotic Plaques via Macrophage Apoptosis-Induced Endothelial Cell ApoptosisNon-lethal sonodynamic therapy facilitates the M1-to-M2 transition in advanced atherosclerotic plaques via activating the ROS-AMPK-mTORC1-autophagy pathwayGerminal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and StabilityMembrane-permeabilized sonodynamic therapy enhances drug delivery into macrophages
P50
Q27342480-729717B1-547A-40DB-9F80-2A501A0CBE0EQ33589049-B623F2F5-45CA-43B5-AE5C-F9EE9B5D8C08Q36206145-13EF00E2-8CBC-4186-AD02-56D0B6C78519Q37074249-A2DB7520-4E2D-4A1E-B542-F52FA0BF1FEFQ37393027-09AB5E1E-68B6-470B-971B-DC06A1EA1FE3Q41349390-082BB33F-42D1-4BBA-A951-25A58A7F3546Q43074066-ECE08B8A-6546-4220-BB1E-5610263A9C3CQ43847224-772C152C-76F4-474C-97DF-D439D5161343Q46799005-56D08A1B-0242-444E-8382-A3040FA3D67FQ47876611-75E753F2-4703-4D8A-AF36-E5BEB1815F04Q50063675-1EFE9C34-BB74-45BD-BE4A-CF82C0CFF664Q52718499-C14286E3-B8B4-4503-8F40-CC1C819E6A5BQ53205345-02B03A7C-64C9-44C8-A8EB-CD994AFDEEB2Q57178038-C023838D-BA0F-4143-A571-B619519F7ECCQ57519250-EB52ED08-C54B-489B-83C7-0B11FB6681CEQ59138144-67ADDB58-FC63-4D66-999A-A4A4A2C83C23Q60924006-E8CEA39E-C26A-4F14-BB1A-BECD220A7FF9Q64105844-3D849067-9E16-45F9-AF9A-9F45668DBE27Q80395955-BA064620-A655-48A9-92D9-926093BACE7DQ83593149-218160B6-17E7-430B-9C3E-B825E097B113Q83689685-00CF499E-0D5E-4040-9A00-F37BF5537354Q84618182-55351DEA-1912-4942-8189-09C8EA3DFE56Q87954909-6A71887D-DA42-4340-A73B-B40E5EA47AB4Q88680536-1A9ECDBB-2FE1-41E1-A4CC-0FBF985B52D4Q89641843-B6127BF4-834C-4C6B-92DC-A4C58E194C8CQ90368032-F8683E1A-5DFF-4DA6-93FC-940AAA1DB178Q92508225-B73F4CF0-C031-4EEA-983D-2EFF7DDB9873Q92632512-EE525BBC-C1B7-4654-B200-ED49E5489883
P50
description
researcher ORCID ID = 0000-0002-8878-6436
@en
name
Hong Jin
@ast
Hong Jin
@en
Hong Jin
@es
Hong Jin
@nl
type
label
Hong Jin
@ast
Hong Jin
@en
Hong Jin
@es
Hong Jin
@nl
prefLabel
Hong Jin
@ast
Hong Jin
@en
Hong Jin
@es
Hong Jin
@nl
P31
P496
0000-0002-8878-6436